Ved afslutningen af de 5 år havde alle patienter HBV DNA niveauer der var udetekterbare eller lavere end præ- behandlingsniveauer.
At the end of 5 years, all patients had HBV DNA levels that were undetectable or lower than pre-treatment levels.